Homologous vs Heterologous Third Vaccination in Kidney Transplant Recipients Kidney Transplant Recipients

NCT05324319 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Ad26COVS1
DRUG: ChAdOx1 SARS2 Vaccine
DRUG: BNT162B2
DRUG: mRNA-1273

Sponsor

Medical University of Vienna